Big Gain For Decibel Therapeutics Inc.

Wed, Jun 29, 2022 at 08:16 PM

Decibel Therapeutics Inc. (DBTX:NASDAQ) soared at $3.82, a gain of 44.2%. On Wed, Jun 29, 2022, DBTX:NASDAQ hit a New 2-Week High of $3.82. The stock got featured on our News Catalysts scanner on Tue, Jun 28, 2022 at 07:19 AM in the 'BIOTECH' category. From Wed, Jun 15, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days

About Decibel Therapeutics Inc. (DBTX:NASDAQ)

Decibel Therapeutics Inc is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders.

Top 10 Gainers:

Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 114.29%
Brickell Biotech, Inc. (BBI:NASDAQ), 47.64%
Decibel Therapeutics Inc. (DBTX:NASDAQ), 44.15%
Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
Aeterna Zentaris Inc. (AEZS:NASDAQ), 39.98%
Aditxt Inc. (ADTX:NASDAQ), 39.76%
PARTS iD Inc. Class A (ID:NYSEMKT), 38.24%
Avenue Therapeutics, Inc. (ATXI:NASDAQ), 32.04%
Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 29.45%
9F Inc. (JFU:NASDAQ), 28.01%